Clinical and Translational Science · 2019 · 21 citations · 28 references
MedicinePharmacologyPharmacogeneticsPharmacogenomicsPrecision MedicineClinical GenomicsClinical Implementation Of PharmacogeneticsClinical Implementation Of PharmacogenomicsClinical TrialsPharmacogenetic TestingPharmacogenomic TestingAdherence To Statin TherapyIntegration Of Pharmacogenomic Results Into Care PlansStatin Pharmacogenomics
Pragmatic clinical trials (PCTs) have an established presence in clinical research and yet have only recently garnered attention within the landscape of genomic medicine. Using the PRagmatic-Explanatory Continuum Indicator Summary 2 (PRECIS-2) as a framework, this paper illustrates the application of PCT principles to The Integrating Pharmacogenetics In Clinical Care (I-PICC) Study, a trial of pharmacogenetic testing prior to statin initiation for cardiovascular disease prevention in primary care. The trial achieved high engagement with providers (85% enrolled of those approached) and enrolled a representative sample of participants for which statin therapy would be recommended. The I-PICC Study has a high level of pragmatism, which should enhance the generalizability of its findings. The PRECIS-2 may be useful in the design and evaluation of PCTs of genomic medicine interventions, contributing to the generation of evidence that can bridge the gap between genomics innovation and clinical adoption.
28
The PRECIS-2 tool: designing trials that are fit for purpose
Kirsty Loudon, Shaun Treweek, Frank Sullivan et al. · BMJ · 2015 · 1.8K citations · Full text
Improving the reporting of pragmatic trials: an extension of the CONSORT statement
Merrick Zwarenstein, Shaun Treweek, Joel Gagnier et al. · BMJ · 2008 · 1.8K citations · Full text
Sean Tunis, Daniel Stryer, Carolyn M. Clancy · JAMA · 2003 · 1.7K citations · Full text